Marcelo Corassa

461 total citations
19 papers, 185 citations indexed

About

Marcelo Corassa is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Marcelo Corassa has authored 19 papers receiving a total of 185 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Marcelo Corassa's work include Cancer Cells and Metastasis (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Sarcoma Diagnosis and Treatment (3 papers). Marcelo Corassa is often cited by papers focused on Cancer Cells and Metastasis (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Sarcoma Diagnosis and Treatment (3 papers). Marcelo Corassa collaborates with scholars based in Brazil, United States and Canada. Marcelo Corassa's co-authors include Emne Ali Abdallah, Ludmilla Thomé Domingos Chinen, Marcello Ferretti Fanelli, Vinícius F. Calsavara, Ulisses Ribaldo Nicolau, Philip C. Mack, Aakash Desai, Jhanelle E. Gray, John R. Gosney and Darko Miljkovic and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Marcelo Corassa

16 papers receiving 182 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcelo Corassa Brazil 7 104 77 64 51 29 19 185
Daniel J. Craig United States 8 96 0.9× 50 0.6× 36 0.6× 51 1.0× 15 0.5× 13 191
Leonardo Rojas Colombia 10 147 1.4× 151 2.0× 61 1.0× 72 1.4× 33 1.1× 40 268
Camilo Garcia France 3 147 1.4× 75 1.0× 35 0.5× 57 1.1× 10 0.3× 10 238
Minjuan Hu China 11 208 2.0× 186 2.4× 86 1.3× 82 1.6× 22 0.8× 28 322
Robert P. Whitehead United States 6 116 1.1× 36 0.5× 49 0.8× 33 0.6× 30 1.0× 19 196
Yan Moore United States 9 112 1.1× 89 1.2× 38 0.6× 98 1.9× 36 1.2× 31 221
James Haberberger United States 9 119 1.1× 103 1.3× 50 0.8× 39 0.8× 8 0.3× 18 204
Kammei Rai Japan 8 104 1.0× 138 1.8× 112 1.8× 144 2.8× 19 0.7× 34 333
Frank Ziemann Germany 8 113 1.1× 57 0.7× 58 0.9× 121 2.4× 31 1.1× 10 259

Countries citing papers authored by Marcelo Corassa

Since Specialization
Citations

This map shows the geographic impact of Marcelo Corassa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcelo Corassa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcelo Corassa more than expected).

Fields of papers citing papers by Marcelo Corassa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcelo Corassa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcelo Corassa. The network helps show where Marcelo Corassa may publish in the future.

Co-authorship network of co-authors of Marcelo Corassa

This figure shows the co-authorship network connecting the top 25 collaborators of Marcelo Corassa. A scholar is included among the top collaborators of Marcelo Corassa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcelo Corassa. Marcelo Corassa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Lenz, Gabriel, Mariah Malak Bilalaga, Nelly Müller, et al.. (2025). Chemotherapy Plus Anti-PD-1 or Anti-PD-L1 in Advanced PD-L1–Negative Squamous Cell Lung Carcinoma: A Systematic Review and Meta-Analysis. Clinical Lung Cancer. 26(6). e361–e373.
2.
Melo, Andréia Cristina de, Roberto Borea, Marcelo Corassa, et al.. (2025). Cancer Incidence and Mortality Estimates in Latin America and the Caribbean: A Systematic Analysis of the GLOBOCAN 2022. Cancer Research Communications. 5(12). 2236–2248.
3.
Desai, Aakash, et al.. (2024). ctDNA for the Evaluation and Management of EGFR-Mutant Non-Small Cell Lung Cancer. Cancers. 16(5). 940–940. 18 indexed citations
4.
Lima, Vladmir Cláudio Cordeiro de, Aline Fusco Fares, Marcelo Corassa, et al.. (2024). Real-world characteristics and outcomes of ERBB2- mutant NSCLC in Latin American patients (CLICaP). The Oncologist. 30(2).
5.
Mantoan, Henrique, Glauco Baiocchi, Giovana Tardin Torrezan, et al.. (2023). Uterine Sarcoma With EML4::NTRK3 Fusion: A Spectrum of Mesenchymal Neoplasms Harboring Actionable Gene Fusions. International Journal of Gynecological Pathology. 43(1). 56–60. 3 indexed citations
6.
Zukin, Mauro, et al.. (2023). P2.16-04 Assessment of the Efficacy and Safety of Durvalumab Associated with Platinum-Etoposide in Previously Untreated ES-SCLC in Brazil. Journal of Thoracic Oncology. 18(11). S376–S376. 1 indexed citations
7.
Loriot, Yohann, Martin Schüler, Gopa Iyer, et al.. (2022). Tumor agnostic efficacy and safety of erdafitinib in patients (pts) with advanced solid tumors with prespecified fibroblast growth factor receptor alterations (FGFRalt) in RAGNAR: Interim analysis (IA) results.. Journal of Clinical Oncology. 40(16_suppl). 3007–3007. 31 indexed citations
8.
Rojo, Federico, Marcelo Corassa, Dimitriοs Mavroudis, et al.. (2020). International real-world study of DLL3 expression in patients with small cell lung cancer. Lung Cancer. 147. 237–243. 42 indexed citations
9.
Freitas, H., Giovana Tardin Torrezan, Isabela Werneck da Cunha, et al.. (2020). Mutational Portrait of Lung Adenocarcinoma in Brazilian Patients: Past, Present, and Future of Molecular Profiling in the Clinic. Frontiers in Oncology. 10. 1068–1068. 12 indexed citations
10.
Cesca, Marcelle Goldner, et al.. (2019). Comparison of enzalutamide versus abiraterone in castration-resistant prostate cancer before docetaxel: Results of a propensity score-matched analysis.. Journal of Clinical Oncology. 37(15_suppl). e16540–e16540. 4 indexed citations
12.
Mello, Celso Abdon Lopes de, Marcelo Corassa, Emne Ali Abdallah, et al.. (2018). EGFR expression in circulating tumor cells from high-grade metastatic soft tissue sarcomas. Cancer Biology & Therapy. 19(6). 454–460. 19 indexed citations
13.
Fanelli, Marcello Ferretti, Thiago Bueno de Oliveira, Marcelo Corassa, et al.. (2017). Evaluation of incidence, significance, and prognostic role of circulating tumor microemboli and transforming growth factor‐β receptor I in head and neck cancer. Head & Neck. 39(11). 2283–2292. 25 indexed citations
15.
Corassa, Marcelo, Solange Moraes Sanches, Marcello Ferretti Fanelli, et al.. (2017). Circulating tumor cells as a new and additional approach to follow-up patients with serous low-grade ovarian adenocarcinoma – a case report and review of the literature. SHILAP Revista de lepidopterología. 37(1). 2 indexed citations
16.
Chinen, Ludmilla Thomé Domingos, et al.. (2017). Circulating Tumor Cells as Cancer Biomarkers in the Clinic. Advances in experimental medicine and biology. 1–41. 20 indexed citations
17.
Corassa, Marcelo, Marcello Ferretti Fanelli, Thiago Bueno de Oliveira, et al.. (2016). Circulating tumor microemboli as a prognostic factor for locally advanced or metastatic solid tumors.. Journal of Clinical Oncology. 34(15_suppl). e23067–e23067. 1 indexed citations
18.
Corassa, Marcelo, et al.. (2013). Extensive Portal and Superior Mesenteric Vein Thrombosis After Splenectomy in a Patient With Hereditary Spherocytosis. 2(2). 79–84. 2 indexed citations
19.
Vicente, António A., et al.. (2013). Thoracic splenosis as a differential diagnosis of juxtapleural nodules. SHILAP Revista de lepidopterología. 11. 1–3. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026